Norepinephrine directly activates adult hippocampal precursors via beta(3)-adrenergic receptors by Jhaveri, Dhanisha J. et al.
Development/Plasticity/Repair
Norepinephrine Directly Activates Adult Hippocampal
Precursors via 3-Adrenergic Receptors
Dhanisha J. Jhaveri,1 EirinnW. Mackay,1 Adam S. Hamlin,1 Swananda V. Marathe,3 L. Sanjay Nandam,1,2
Vidita A. Vaidya,3 and Perry F. Bartlett1
1The Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia, 2The Prince Charles Hospital, Brisbane, Queensland
4032, Australia, and 3Department of Biological Sciences, Tata Institute of Fundamental Research, Mumbai 400005, India
Adult hippocampal neurogenesis is a critical form of cellular plasticity that is greatly influenced by neural activity. Among the neuro-
transmitters that are widely implicated in regulating this process are serotonin and norepinephrine, levels of which are modulated by
stress, depression and clinical antidepressants.However, studies to date have failed to address a direct role for either neurotransmitter in
regulating hippocampal precursor activity. Here we show that norepinephrine but not serotonin directly activates self-renewing and
multipotent neural precursors, including stem cells, from the hippocampus of adult mice. Mechanistically, we provide evidence that
3-adrenergic receptors, which are preferentially expressed on a Hes5-expressing precursor population in the subgranular zone (SGZ),
mediate this norepinephrine-dependent activation. Moreover, intrahippocampal injection of a selective3-adrenergic receptor agonist
in vivo increases the number of proliferating cells in the SGZ. Similarly, systemic injection of the -adrenergic receptor agonist isopro-
terenol not only results in enhancement of proliferation in the SGZ but also leads to an increase in the percentage of nestin/glial fibrillary
acidic protein double-positive neural precursors in vivo. Finally, using a novel ex vivo “slice-sphere” assay that maintains an intact
neurogenic niche,wedemonstrate that antidepressants that selectively block the reuptake of norepinephrine, but not serotonin, robustly
increase hippocampal precursor activity via-adrenergic receptors. These findings suggest that the activation of neurogenic precursors
and stem cells via3-adrenergic receptors could be a potentmechanism to increase neuronal production, providing a putative target for
the development of novel antidepressants.
Introduction
The adult mammalian hippocampus harbors neural precursors
that reside and proliferate in the milieu of the neurogenic niche
(Ming and Song, 2005) to generate neurons that functionally
integrate into the hippocampal neurocircuitry, thereby influenc-
ing functions such as learning and memory (Lledo et al., 2006).
Accumulating evidence has suggested an important role for syn-
aptic activity in regulating this process (Ming and Song, 2005;
Zhao et al., 2008). Neural excitation has been shown to activate a
latent stem cell pool (Walker et al., 2008), to promote the com-
mitment of precursors to a neurogenic fate (Deisseroth et al.,
2004), as well as to enhance the survival and integration of newly
born neurons in the adult hippocampus (Ge et al., 2006; Tashiro
et al., 2006). Among the factors that are released following syn-
aptic activity are the neurotransmitters, trophic roles for which
are increasingly being appreciated in the regulation of neurogen-
esis (Vaidya et al., 2007; Hagg, 2009). Recent studies have also
shown that glutamate and GABA receptors are present on a sub-
set of adult hippocampal precursors and regulate their prolifera-
tion (Ge et al., 2007; Na´cher et al., 2007).
Within the monoaminergic neurotransmitter family, a large
number of in vivo studies have focused on the roles of serotonin
and norepinephrine (NE), revealing a strong correlation between
their levels and the extent of hippocampal neurogenesis (Brezun
and Daszuta, 1999, 2000; Kulkarni et al., 2002) Furthermore,
impaired neurogenesis has been demonstrated in animal models
of stress and depression (Malberg andDuman, 2003; Vollmayr et
al., 2007), where a significant reduction in the levels of serotonin
and norepinephrine is also commonly observed (Charney, 1998;
Vaidya et al., 2007). In agreement with these lines of evidence,
pharmacological agents, such as antidepressants that act by ele-
vating levels of serotonin and norepinephrine, have been shown
to enhance hippocampal neurogenesis (Malberg et al., 2000). To
date, a proliferative role has been proposed for norepinephrine
(Kulkarni et al., 2002), whereas controversy still exists regarding
the role of serotonin in regulating the proliferation of hippocam-
pal precursors (Santarelli et al., 2003; Encinas et al., 2006; Holick
et al., 2008; Huang et al., 2008). However, one of the limitations
of the current in vivo approaches is the inability to dissect out
direct versus non-cell-autonomous effects of these neurotrans-
mitters on the precursor population. Whether serotonin or nor-
epinephrine has a direct effect on adult hippocampal precursors,
and the cellular and molecular identity of such a precursor pop-
ulation, therefore remains unknown.
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In the present study, we investigated the effects of serotonin
and norepinephrine on adult hippocampal precursors in vitro
using the neurosphere assay. We report that norepinephrine but
not serotonin directly activates a self-renewing and multipotent
population of stem and precursor cells. We then demonstrate
that this effect is mediated by 3-adrenergic receptors both in
vitro and in vivo. Finally, we examine the effects of two major
classes of widely prescribed antidepressants in a novel slice-
sphere assay and show that norepinephrine-selective reuptake
inhibitors (NRIs) but not serotonin-selective reuptake inhibitors
(SSRIs) significantly enhance hippocampal neural precursor ac-
tivity via -adrenergic receptors.
Materials andMethods
Animals.Adultmale (8–12 weeks old)mice were used for themajority of
the experiments in this study except for the slice-sphere assay where
postnatal day 7 Wistar pups were used. Mice expressing enhanced green
fluorescent protein (GFP) under the control of the Hes5 promoter were
generated by theGeneExpression andNervous SystemAtlasConsortium
(Gensat) and were obtained from the Mutant Mouse Regional Resource
Center (University of Missouri). Adult male Nestin-GFP mice, main-
tained on a C57BL/6 background were generated as previously described
(Yu et al., 2005). Animals were treated in accordance with the Australian
Code of Practice for the Care and Use of Animals for Scientific Purposes
and ethics approval was obtained for all experiments from the appropri-
ate institutional Animal Ethics Committee.
Adult hippocampal neurosphere culture.AdultmaleC57BL/6micewere
killed by cervical dislocation and their brains removed. Brains were bi-
sected along the midline in the sagittal plane. The hippocampi were
isolated from the overlying cortex and minced using a scalpel blade.
Minced tissue was digested in 0.1% papain (Invitrogen) for 20 min at
37°C, after which an excess of NeuroCult NSC basal medium (StemCell
Technologies) was added to halt the digestion. Tissue was then centri-
fuged at 100 relative centrifugal force for 5 min, the resulting pellet was
resuspended in 1 ml of complete neurosphere medium, and a single-cell
suspension was achieved by gentle trituration. The cells were filtered
through a 40 m cell sieve (BD Biosciences) and resuspended in Neuro-
Cult NSC basal medium containing NeuroCult proliferation supple-
ments (StemCell Technologies), 2% bovine serum albumin (Invitrogen)
and 2g/ml heparin (Sigma-Aldrich). The growth factors added were 20
ng/ml epidermal growth factor (EGF; receptor grade, BD Biosciences)
and 10 ng/ml basic fibroblast growth factor (bFGF; recombinant bovine,
Roche). The cells were then plated in a 96-well plate and cultured in
complete neurosphere medium containing EGF and bFGF, in the pres-
ence or absence of 5-hydroxytryptamine hydrochloride (serotonin; 100
nM, 1M, 10M), L-()-noradrenaline ()-bitartrate salt monohydrate
(norepinephrine; 100 nM, 1 M, 10 M) or KCl (15 mM). The concentra-
tions of norepinephrine and serotonin used were based on previous re-
ports (Segal, 1980; Lacaille and Harley, 1985). The adrenergic receptor
antagonists usedwere prazosin (100 nM), yohimbine (1M), propranolol
(1M), CGP20712 ([2-(3-carbamoyl-4-hydroxyphenoxy)-ethylamino]-
3-[4-(1-methyl-4-trifluormethyl-2-imidazolyl)-phenoxy]-2-propanol-
methanesulfonate) (10 nM), ICI118,551 (3-(isopropylamino)-1-[(7-
methyl-4-indanyl)oxy]butan-2-ol) (10 nM), and SR59230A [(3-(2-
ethylphenoxy)-1-[(1S)-1,2,3,4-tetrahydronaphth-1-ylamino]-(2S)-2-
propanol oxalate)] (10 nM). BRL37344 [()-(R*,R*)-[4-[2-[[2-(3-
chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetic acid sodium
hydrate] was used as a selective 3-adrenergic receptor agonist (1 and 10
M). All the compounds were purchased from Sigma-Aldrich. The number
of primary neurospheres was counted on days 10–13 and expressed as a
percentage relative to the control. Passaging of single primary neurospheres
was done essentially as described byWalker et al. (2008).
Immunocytochemistry. Control or norepinephrine-stimulated neuro-
spheres were plated onto poly-ornithine-coated coverslips or poly-D-
lysine-coated BioCoat eight-well culture slides (BD Biosciences) in
serum-free basal mediumwithout anymitogens. The neurospheres were
allowed to flatten and adhere for 4–6 d in a humidified, 5% CO2 incu-
bator. They were then fixed with 4% paraformaldehyde in 0.1 M PBS at
4°C for 40 min, and immunocytochemistry was performed as described
previously (Bull andBartlett, 2005) using antibodies to the neuronalmarker
III tubulin (1:2000; Promega), the astrocytic marker glial fibrillary
acidic protein (GFAP; 1:500;DakoCytomation) and the oligodendrocyte
marker myelin basic protein (MBP; 1:500; Millipore). 4,6-Diamidino-
2-phenylindole (DAPI; 1:5000; Sigma-Aldrich) was used as a nuclear
stain. Slides were mounted using fluoromount (Dako Cytomation) and
viewed on a Zeiss-Axio Imager microscope. Images were captured using
a digital camera linked to a computer using Zeiss software.
Surgery and drug treatments. Adult male C57BL/6 mice were anesthe-
tized with amixture of ketamine (130mg/kg; Apex Laboratories) and the
muscle relaxant xylazine (6mg/kg; Bayer). Themouse was then placed in
a stereotaxic frame (David Kopf Instruments), with the incisor barmain-
tained at 3.3 mm below horizontal to achieve a flat skull position.
Bilateral injections were performed using a glass needle (exterior diam-
eter 20 m) fashioned from a borosilicate glass capillary (World Preci-
sion Instruments) and attached to a 5 l Hamilton syringe. The needle
was lowered into the hilus region of the hippocampus (anteroposterior,
1.3 mm; mediolateral, 0.9 mm; dorsoventrial, 2.0 mm from
bregma). The hilus fromone hemisphere received an injection (0.5l) of
the selective 3-adrenergic receptor agonist BRL37344 (10M); with the
contralateral hemisphere receiving a control injection of 0.9% saline.
Infusions were conducted over 5 min and the needle was left in place for
a further 10min to allow for diffusion. At 1 and 24 h following surgery all
mice received injections (75 mg/kg, i.p.) of bromodeoxyuridine (BrdU).
Three days after the initial BRL37344 infusion, the animals were deeply
anesthetized with sodium pentobarbital (100 mg/kg, i.p.) and transcar-
dially perfused with 4% paraformaldehyde in 0.1 M PBS. Brains were
blocked using amatrix (Stoelting) aligned to themouse brain atlas (Paxinos
and Franklin, 2001), and 40 m coronal sections were cut through the
hippocampus using a sliding microtome (Leica, SM2000r) in four seri-
ally adjacent sets and stored in 0.1% sodium azide in 0.1 M PBS. One set
of sections (160 m apart) was processed for BrdU immunohistochem-
istry, while the second set of sections was mounted on a chrome alum/
gelatinized glass slide and stained with cresyl violet. Injection placements
were verified under the microscope using the boundaries defined by
Paxinos and Franklin (2001).
To study the influence of -adrenergic receptor stimulation on adult
hippocampal progenitors, the -adrenergic receptor agonist, isoproter-
enol (2 mg/kg, Sigma) was used. The choice of drug dose was based on
previous studies (Ozawa et al., 1969; Yuan et al., 2000), with 0.9% saline
being used as the vehicle. Nestin-GFP mice received the drug via intra-
peritoneal injection, once daily for seven d. All mice received BrdU (100
mg/kg, i.p.) 2 h following the last injection and were killed 24 h later by
transcardial perfusion using 4% paraformaldehyde.
Immunohistochemistry. Hes5-GFP mice were perfused transcardially
using ice-cold 4% paraformaldehyde. Brains were removed and post-
fixed in 4% paraformaldehyde for 24 h, after which 50 m sections were
cut using a freezing microtome. The sections were blocked in PBS con-
taining 0.1%TritonX-100 (0.1%PBTX) and 10%normal goat serum for
1 h and then labeled with primary antibodies: anti-GFAP (1:500; Dako
Cytomation), anti-doublecortin (1:500; Sapphire Bioscience) and anti-
nestin (1:100, Developmental Studies Hybridoma Bank, University of
Iowa, Iowa City, IA). The sections were washed three times using 0.1%
PBTX and incubated for 2 h at room temperature with the secondary
antibodies goat anti-mouse Alexa 568 or goat anti-rabbit Alexa 568 (1:
2000, Invitrogen), andDAPI (1:1000). BrdU immunohistochemistrywas
performed essentially as described previously (Kulkarni et al., 2002; Jha
et al., 2006). In brief, this involvedDNAdenaturation and acid hydrolysis
followed by overnight incubation with mouse anti-BrdU antibody (1:
500; Roche). The secondary antibody goat anti-mouse Alexa 488 (In-
vitrogen) was used at 1:2000. After several washes, the sections were
mounted using fluoromount (Dako Cytomation) and viewed on a Zeiss-
Axio Imager microscope. Optical sectioning was achieved using Apo-
Tome and images were captured using a digital camera linked to a
computer using Zeiss software.
For double-label immunofluorescence for GFP and GFAP in nestin-
GFP mice, 4 sections (50 m) were selected per animal. The choice of
sections was such that they were from comparable bregma points across
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all experimental animals. The sections were incubated for 2 h with 10%
horse serum (Invitrogen) before an overnight incubation at room tem-
perature with a mixture of the primary antibodies, rabbit anti-GFP (1:
500, Invitrogen) and mouse anti-GFAP (1:1000, Sigma). Sections were
then incubated with the secondary antibodies, donkey anti-rabbit IgG
(1:250, Invitrogen) and donkey anti-mouse IgG (1:250, Invitrogen) for
4 h at room temperature.
Cell counting analysis. Analysis was performed on coded sections by
an experimenter blind to the study code. To address the effects of
-adrenergic receptor stimulation on nestin/GFAP double-positive
quiescent progenitors, the percentage of GFP-positive cells that colo-
calized with GFAP was determined by confocal microscopy using an
Olympus FV1000 confocal microscope. Between 30 and 40 GFP-
positive cells from four sections (250 m apart) per animal were
analyzed using z-plane confocal sectioning with 1 m steps to con-
firm colocalization of GFP with GFAP.
Fluorescence-activated cell sorting. Brains from adult male Hes5-GFP
mice were removed and hippocampi were isolated as described earlier. A
live-cell suspensionwasprepared fromthehippocampususing0.1%papain,
and the dead cells were labeled with propidium iodide (1 g/ml). GFP-
positive and -negative cells were purified by fluorescence-activated cell sort-
ing (FACS). Cells were sorted on a FACS Vantage (Becton Dickinson) with
DIVA software. The GFP-negative populations was set relative to the basal
fluorescence levels obtained from GFP-negative wild-type littermate con-
trols and a conservative approach was used in selecting only high GFP-
expressing cells. The cells were collected in basal medium and plated into
96-well tissue culture plates in medium containing EGF and bFGF with
or without norepinephrine (10 M).
RNA extraction and cDNA synthesis. RNA was extracted from sorted
Hes5-GFP-positive and -negative cells using the RNeasy Mini Kit (Qia-
gen). Genomic DNAwas removed by DNase digestion using a DNA-free
kit (Ambion). cDNA was generated using SuperScript III (Invitrogen)
with oligo-dT primers.
PCR. The complete list of primer sequences used for the PCR is de-
tailed in Table 1. Program 1 involved initial denaturation at 95°C for 2
min, followed by 35 cycles of 95°C for 1 min and 70°C for 2 min, with a
final elongation step of 72°C for 5min as described by (Cikos et al., 2005).
Program 2 began with initial denaturation at 95°C for 2min, followed by
32 cycles of 95°C for 30 s, 64°C for 30 s, and 72°C for 30 s, essentially as
described by Evans et al. (1999). A total of 45 cycles were used to amplify
the 3-adrenergic receptor (Adrb3).
Generation of hippocampal organotypic slices. Seven-day-old Wistar
pups were killed under isoflurane-induced anesthesia, and the brains
were isolated andplaced in ice-coldRinger’s solution (containing, inmM:
118NaCl, 2.5 KCl, 1.2 NaH2PO4, 2.5 CaCl2, 1.3MgCl2, 25NaHCO3, and
10 glucose, pH 7.2). The brain was bisected along the sagittal plane and
the hippocampi were separated from the overlying cortex. The hip-
pocampiwere cut into transverse slices of 300mthickness using a tissue
slicer (Stoelting). Six to seven slices were then transferred onto a single
0.4 m Millicell-CM membrane filter (Millipore), and the filters were
placed in a 6-well plate containing 1 ml of serum-free NeuroCult NSC
basal medium with NeuroCult proliferation supplements (StemCell
Technologies) and 2% bovine serum albumin (Invitrogen). D-Glucose
(Sigma-Aldrich) was added to the medium to a final concentration of 5
mM. Four filters, each containing 6–7 hippocampal slices, were generated
from a single animal. Plates were incubated at 37°C in a humidified 5%
CO2 incubator and the slices were cultured for 6 d.
Pharmacological treatment of hippocampal slices. To assess the influ-
ence of specific compounds on hippocampal precursor proliferation in
the slice culture, compounds were added to the complete medium at the
doses outlined below. Two filters were treated with the compounds for
each dose per experiment. On every alternate day half the medium was
removed and replaced with fresh medium containing the compounds.
Slices were treated with serotonin at 10 and 100 M and norepinephrine
at 1M, 10 and 100M. The antidepressants used were fluoxetine (1 and
10 M), citalopram (10 and 100 M), reboxetine (1 M, 10 and 100 M),
atomoxetine (1 M) and maprotiline (1 M). Propranolol (10 M) was
used to block -adrenergic receptors in the slices.
Derivation of neurospheres from hippocampal organotypic slices.On the
sixth day of culture, the hippocampal slices from each treatment group
were pooled and the tissue was minced using a scalpel blade. Minced
tissuewas then treatedwith 0.1% trypsin-EDTA (Invitrogen) for 5min at
37°C. The digestion was stopped by adding 0.014%w/v trypsin inhibitor
(Sigma-Aldrich). A single-cell suspension was achieved by gentle tritu-
ration. The total number of viable cells in an aliquot was counted on a
hemocytometer based on the exclusion of 0.08% trypan blue (Sigma-
Aldrich). The cells were then cultured in complete neurosphere medium
containing EGF and bFGF. A 200 l cell suspension was plated at 2500
cells/ml in a 96-well plate, resulting in a cell density of 500 cells/well. For
each experiment there were 20 wells plated for each of the doses per
treatment group. The plates were incubated at 37°C in a humidified 5%
CO2 incubator. The number of neurospheres obtained per well was
counted after 10 d in culture and expressed as a percentage of the control.
Statistical analysis. Experiments were repeated three times unless oth-
erwise stated and the values expressed as mean  SEM. Results were
subjected to statistical analysis using the statistical software Prism
(GraphPad) and analyzed using either Student’s t tests or one-way
ANOVA with significance determined at p 0.05 followed by the Bon-
ferroni post hoc test.
Results
Norepinephrine but not serotonin activates adult
hippocampal stem and precursor cells and promotes
neurogenesis in vitro
To examine the effect of serotonin and norepinephrine in regu-
lating adult hippocampal precursor activity, we used the classical
neurosphere assay in the presence of the conventional mitogens
EGF and bFGF. The addition of serotonin at 100 nM, 1 or 10 M
produced no change in neurosphere numbers (Fig. 1A) or size
(supplemental Fig. 1, available at www.jneurosci.org as supple-
mental material) compared with the control. In contrast, a sig-
nificant increase was obtained in the presence of 100 nM and 1M
norepinephrine, with a twofold increase in neurosphere numbers
observed in the presence of 10 M norepinephrine ( p 0.001,
unpaired t test; Fig. 1A). The average size of the neurospheres
derived in the presence of 1 and 10 M norepinephrine (diam-
eter of neurosphere in m; control: 83.47  2.5; 100 nM NE:
78.2 1.5; 1MNE: 99.33 2.2; 10MNE: 113.95 5.4) was
also significantly greater than that of the control neurospheres
( p  0.01 in both cases; unpaired t test). Importantly, there
was also the emergence of a population of very large neuro-
spheres 200 m in diameter in the presence of 10 M norepi-
nephrine (Fig. 1B,C). Furthermore, a systematic categorization
of neurospheres according to their size revealed not only a signif-
icant increase in the percentage of neurospheres measuring 100–
150 m ( p  0.012), 150–200 m ( p  0.007) and 200 m
( p  0.004) but a concomitant reduction in the smaller neuro-
spheres measuring100m ( p 0.001) in norepinephrine (10
M) comparedwith the control (Fig. 1D). The large (200min
diameter) norepinephrine-derived neurospheres resembled
those described previously (Walker et al., 2008) following treat-
ment with depolarizing levels of KCl, suggesting activation of a
latent stem cell pool.
Table 1. Gene-specific primer sequences for reverse transcriptase-PCR
Target Forward Reverse
Product
(bp) Program
Adrb1 ggagctccctcggacgac agcctggctctctacaccttg 173 1
Adrb2 gtactgtgcctagccttagcgt ggttagtgtcctgtcaaggagg 115 1
Adrb3 tctagttcccagcggagttttcatcg cgcgcaccttcatagccatcaaacc 234 2
Hes5 aagtaccgtggcggtggagatgc cgctggaagtggtaaagcagctt 354 2
Enhanced GFP cctacggcgtgcagtgcttcagc cggcgagctgcacgctgcgtcctc 300 2
Actin agaagagctatgagctgcctgacg tacttgcgctcaggaggagcaatg 301 2
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To ascertain whether the norepinephrine-stimulated large
neurospheres indeed reflected the activation of stem cells,
individual neurospheres were selected and subjected to long-
term passaging to assess their self-renewal capacity. A signifi-
cant proportion (71.4%, 15 of 21) of norepinephrine (10 M)
stimulated large neurospheres (200 m in diameter) could
be passaged over 10 times (Fig. 2A) compared to none of the
smaller neurospheres (200 m in diameter) from the con-
trol or norepinephrine-treated groups. Similarly, none of the
neurospheres (0 of 16) stimulated with either 1 or 10 M
serotonin could be passaged.
We next determined the multipotentiality of the cells
present within the neurospheres generated in the presence or
absence of norepinephrine (Fig. 2B–D). All the neurospheres
examined contained GFAP-expressing astrocytes. However,
only a small proportion (4 of 26 neurospheres examined) of
the control neurospheres contained III tubulin-positive neu-
rons, as opposed to the majority (62 of 82 neurospheres exam-
ined) of the norepinephrine-stimulated neurospheres. One third
of the norepinephrine-stimulated neurospheres containedMBP-
positive oligodendrocytes (Fig. 2E), whereas none of the control
neurospheres expressed the oligodendrocytic marker. Notably,
all the norepinephrine-stimulated large neurospheres examined
(n  9) contained 50 neurons. Together, these findings indi-
cate that norepinephrine but not serotonin can activate a self-
renewing and multipotent stem cell population in the adult
hippocampus.
To examine whether norepinephrine and KCl activate the
same latent pool of precursors, we added both KCl (15 mM) and
norepinephrine (10 M) to the cultures. This led to a 4.5-fold
increase in total neurosphere numbers compared with the two-
fold increase observed in the presence of either norepinephrine
or KCl alone ( p 0.05, unpaired t test), suggesting that separate
populations of precursors were being activated (Fig. 3A). More
importantly, there was a fivefold increase in the number of large
neurospheres (200mindiameter) in the combined treatment
group (control: 0; NE: 7.0 0; KCl: 6.5 5.5; NEKCl: 34.5
7.5; n  2 experiments), indicative of activation a much larger
population of latent stem cells than previously thought (Fig. 3B)
(Walker et al., 2008).
Norepinephrine directly stimulates proliferation of a
Hes5-expressing stem and precursor cell population
To determine whether norepinephrine can directly activate hip-
pocampal precursors, it was necessary to examine the effect of
norepinephrine at a clonal density. Given the very low frequency
of neurosphere formation from the adult hippocampus (Bull and
Bartlett, 2005), we needed to enrich cells with neurosphere-
forming activity based on the use of an appropriate marker.
Notch signaling has been implicated in themaintenance of neural
precursors, and transgenic mice expressing GFP driven by the
promoter of one of the downstream effectors of Notch, Hes5,
have been used previously to isolate and enrich multipotential
stem cells in the embryonic nervous system (Ohtsuka et al., 2006;
Basak andTaylor, 2007).We therefore investigatedwhetherHes5
could also be used as amarker to isolate and enrich for hippocam-
pal precursors in the adult. Using Hes5-GFP transgenic mice, we
examined the expression pattern in the adult hippocampus and
found that GFP-expressing cells were predominantly located
along the subgranular zone (SGZ) of the dentate gyrus and had a
radial glia-like morphology (Fig. 4A). The restricted expression
and the characteristic morphology of the Hes5-GFP-positive
cells prompted us to further examine whether this population
represented stem/precursor cells. When colabeling with known
stem/precursor cell markers was analyzed in 3–5 sections per
hippocampus (n  4 hippocampi) we found that 39% of the
Hes5-GFP-positive cells in the SGZ (total of 927 cells examined)
expressedGFAP, amarker for quiescent neural precursor or neu-
ral stem-like cells (Fig. 4B,B), whereas 40% expressed nestin,
another marker for the precursor population (total of 477 cells
examined; Fig. 4C,C), suggesting that the Hes5-GFP-positive
Figure 1. Norepinephrine but not serotonin activates a precursor cell population from the
adult hippocampus. A–C, Treatment of adult hippocampal cells with NE but not serotonin
(5-HT) in the presence of EGF and bFGF significantly enhanced neurosphere formation with up
to a twofold increase observed at 10 M (mean  SEM; ***p  0.001) (A). In addition,
norepinephrine treatment generated a number of very large neurospheres, an example of
which is shown in C, compared with smaller neurospheres generated in the control (B). Scale
bars, 100m.D, Neurospheres obtained in the presence of 10M norepinephrinewere signif-
icantly larger than the control neurospheres. Note an increase in the percentage of
norepinephrine-derived neurospheres measuring 100–150 m, 150–200 m, and200
m, but a reduction in the smaller neurospheres measuring100 m compared with the
control neurospheres (mean SEM; *p 0.05, **p 0.01***p 0.001).
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cells were part of a stem/precursor cell population. No colabeling
was observed between doublecortin- and GFP-positive cells (Fig.
4D), indicating that Hes5-GFP does not label neuronal progeni-
tors or newly born neurons, although several doublecortin-
positive cells were found in juxtaposition with GFP-expressing
cells in the SGZ (Fig. 4D).
Next, to examine the stem cell potential of the Hes5-GFP-
expressing cells, cells were sorted from the adult hippocampus
based on GFP expression (Fig. 5A). Reverse transcriptase-PCR
analysis of the sorted cells showed the presence of Hes5 mRNA
only in the GFP-positive population (Fig. 5B), which represented
5.6 0.5% (n 5 experiments) of the total viable hippocampal
cell population. Subsequently, GFP-positive and -negative cells
purified using flow cytometry were cultured for neurosphere
generation. On average we observed that 1 of 65.5  15.2 GFP-
positive cells formed a neurosphere in control medium contain-
ing EGF and bFGF, with no neurospheres being obtained from
the GFP-negative fraction (Fig. 5C). More importantly, the addi-
tion of norepinephrine resulted in a twofold increase in total
neurosphere numbers only in the GFP-positive population (Fig.
5C), with the appearance of very large neurospheres (200min
diameter) as described above (control: 1.0 0.5 neurospheres vs
NE: 7.3  0.8 neurospheres per hippocampus). Together, these
findings identify Hes5 as a marker of a stem and precursor cell
population in the adult hippocampus, including those cells re-
sponsive to norepinephrine, and rule out the influence of Hes5-
GFP-negative cells on neurosphere formation.
Finally, to determine whether norepi-
nephrine activated the stem cell popula-
tion directly and not via release of other
factors in a paracrine manner in the bulk
cultures, Hes5-GFP-positive cells were
plated at a clonal density in 96-well plates.
Whereas 1 of 32.5 3.1GFP-positive cells
formed a neurosphere in the control me-
dium, the frequency in the medium con-
taining norepinephrine was 1 of 15.5 1.6,
resulting in a 215.4  23.5% increase in
neurosphere numbers, similar to that ob-
tained in the bulk cultures. Moreover, even
at clonal density a number of large neuro-
spheres (200 m) expressing GFP were
observed in the presence of norepinephrine
(data not shown). Together, these findings
unequivocally demonstrate that the effect of
norepinephrine is direct and specific to hip-
pocampal neural precursors.
3-Adrenergic receptors mediate the
effects of norepinephrine
Given that norepinephrine directly acti-
vated hippocampal precursors, we next
sought to identify the adrenergic receptor(s)
mediating this effect. Adrenergic receptors
are a diverse family of receptors divided into
two major subclasses,  and , with six
members of the  family and three mem-
bers of the  family identified to date. The
hippocampal cells were treated with spe-
cific antagonists to 1-adrenergic recep-
tors (prazosin), 2-adrenergic receptors
(yohimbine), or -adrenergic receptors
(propranolol) in the presence or absence
of norepinephrine (Fig. 6A). One-way ANOVA revealed a signif-
icant difference between groups [F(7,20) 8.0, p 0.0001]. Both
prazosin (100 nM) and yohimbine (1 M) failed to inhibit the
increase in neurosphere numbers observed in the presence
of norepinephrine, whereas propranolol (1 M) reduced the
norepinephrine-mediated response back to control levels ( p 
0.01; Bonferroni post hoc test), suggesting that -adrenergic re-
ceptors are required for norepinephrine-dependent activation of
precursors. Interestingly, treatment with yohimbine in the ab-
sence of norepinephrine resulted in a significant 40% increase
( p  0.05) in the neurosphere numbers compared with the
control.
Next, to identify the subtype of -adrenergic receptor involved,
we tested selective antagonists to1-,2-, and3-adrenergic recep-
tors (Fig. 6B). One-way ANOVA revealed a significant difference
between groups [F(7,16) 42.5, p 0.0001]. CGP20712 (10 nM),
a 1-adrenergic receptor antagonist, had no effect ( p  0.05;
Bonferroni post hoc test), whereas the 2-adrenergic receptor
blocker ICI118,551 (10 nM) significantly enhanced ( p  0.05;
Bonferroni post hoc test) the norepinephrine-mediated response.
Moreover, ICI118,551 in the absence of norepinephrine also in-
creased neurosphere generation by34% ( p 0.05) compared
with the control. Only SR59230A (10 nM), a specific 3-adrenergic
receptor antagonist, completely blocked the norepinephrine-
mediated activation of precursors ( p  0.001), and also sig-
nificantly reduced the generation of very large neurospheres
(NE: 12  2.08 neurospheres vs NESR59230A: 3.33  0.88
Figure 2. Hippocampal precursors activated by norepinephrine are self-renewing and multipotent. A, A large increase in cell
numbers was observed when a single norepinephrine-derived large neurosphere was passaged up to 10 times. B, Relative per-
centage of the primary neurospheres expressingmarkers of astrocytes, neurons and oligodendrocytes in control versus NE-treated
cultures. Note that all neurospheres examined contained GFAP-positive astrocytes. However, a significantly larger proportion of
neurospheres expressed the neuronal marker, III tubulin, in the norepinephrine-treated vs the control group. MBP-positive
oligodendrocytes were only present in norepinephrine-stimulated neurospheres. C, D, An example of control (C) and
norepinephrine-derived (D) neurospheres showing immunofluorescence for GFAP (green) and III tubulin (red). Nuclei were
stained with DAPI (blue). Scale bars, 100 m. Note the presence of a large number of III tubulin-positive neurons in the
norepinephrine-derived sphere. E, MBP-expressing oligodendrocytes (green) were also present in norepinephrine-stimulated
neurospheres. Scale bar, 30m.
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neurospheres; p 0.018; unpaired t test). Similarly, a significant
block in norepinephrine-mediated activationwas observedwhen
the purified Hes5-GFP-positive precursor population was treated
with SR59230A (control: 28  1.0 neurospheres, NE: 45.5  2.5
neurospheres, NESR59230A: 26.5 2.5 neurospheres; n 2 ex-
periments; p 0.016, unpaired t test).
Importantly, reverse transcriptase-PCR analysis showed the
presence of 3-adrenergic receptors exclusively in the Hes5-
positive population, whereas 1- and 2-adrenergic receptors
were expressed predominantly in the Hes5-negative population
(Fig. 6C). A small amount of 2-adrenergic receptor was also
detected in the Hes5-positive cells.
Together the above findings led us to examine the effect of a
selective 3-adrenergic receptor agonist BRL37344 on neural
precursor activity (Fig. 6D). One-way ANOVA revealed a signif-
icant difference between groups [F(3,20)  16.14, p  0.0001].
Addition of BRL37344 (1 or 10 M) or norepinephrine led to a
significant increase in neurosphere numbers compared with the
control ( p  0.001; Bonferroni post hoc test). Importantly,
BRL37344 (either 1M or10M) treatment increased the neuro-
sphere numbers to a similar extent to that obtained by norepi-
nephrine treatment. Moreover, several very large neurospheres
(200 m in diameter), indicative of activation of stem cells,
were observed in BRL37344-treated cultures (1 M BRL37344:
5.5  0.5 neurospheres and 10 M BRL37344: 7.5  0.5 neuro-
spheres) compared to none in the control medium.
Stimulation of3-adrenergic receptors increases
proliferation of hippocampal precursors in vivo
To determine whether similar enhancement of neural precursor
activity occurs following stimulation of 3-adrenergic receptors
in vivo, we injected BRL37344 directly into the hippocampus
(Fig. 7A–C), given the absence of any direct evidence that
BRL37344 is systemically active and crosses the blood–brain bar-
rier. A single dose of BRL37344 (0.5 l of 10 M) was injected
Figure3. Norepinephrine and KCl activate different populations of hippocampal precursors.
A, Culturing adult hippocampal cells in the presence of NE and KCl resulted in over a 4.5-fold
increase in neurosphere numbers compared with a twofold increase in the number of
neurospheres observed in the presence of either norepinephrine or KCl alone (mean
SEM; *p  0.05). B, Distribution of neurospheres according to size showing approxi-
mately a fivefold increase in the number of large neurospheres, measuring200 m,
obtained in the presence of NEKCl (mean SEM; *p 0.05, **p 0.01).
Figure4. Hes5-GFP-positive cells coexpressmarkers of stem cells in the adult dentate gyrus.
A, Hes5-GFP-positive cells are predominantly present along the subgranular zone and extend
radial-glia like processes through the granule cell layer (GCL) in the adult dentate gyrus.B–D,
Hes5-GFP-positive cells coexpressmarkers of stemcells suchasGFAP (red;B) andnestin (red;C).
The coexpression is seen predominantly along the processes of the Hes5-GFP-positive cells
(arrowheads; B, C). No coexpression was seenwith doublecortin (red;D), a marker of newly
born neurons. However, doublecortin-positive cells were mainly found in juxtaposition
with Hes5-GFP-positive cells (arrowheads; D). Nuclei were labeled with DAPI (blue).
Scale bars, 100m.
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directly into the hilus region on the ipsilateral side, with saline
(vehicle control) being injected into the contralateral side; divid-
ing cells were then labeledwith BrdU. A significant increase in the
linear density of BrdU-positive cells (expressed as number of
BrdU-labeled cells per mm of SGZ) was observed in the SGZ of
the BRL37344-injected hippocampus compared with the con-
tralateral saline-injected hippocampus (Fig. 7D,E; saline: 9.59
1.3 cells vs BRL37344: 13.36 2.0 cells; n 5; p 0.023; paired
t test). This finding demonstrates that 3-adrenergic receptor
stimulation leads to proliferation of neural precursors in vivo.
We also examined the effect of systemic treatment with the
-adrenergic receptor agonist isoproterenol on hippocampal
Figure 5. Norepinephrine activates a Hes5-expressing precursor population. A, Hes5-GFP-
positive and -negative cells were sorted using flow cytometry based on their GFP expression.
FSC, Forward scatter.B, Reverse transcriptase-PCRanalysis revealed thepresenceofHes5mRNA
only in the GFP-positive population. C, The Hes5-GFP-positive population contained all the
neurosphere-forming cells. Note that in the presence of norepinephrine almost twice as many
neurospheres were obtained from the Hes5-GFP-positive population. No neurospheres were
generated from the Hes5-GFP-negative population (mean SEM; ***p 0.001).
Figure 6. 3 receptors are expressed on neural precursors, and mediate the norepine-
phrine-dependent activation. A, Neither the 1-adrenergic receptor antagonist prazosin nor
the 2-adrenergic receptor blocker yohimbine had any effect on the norepinephrine-
stimulated increase in neurosphere numbers. Only the-adrenergic receptor blocker, propran-
olol, completely inhibited the norepinephrine-stimulated increase in neurosphere numbers.
Note that treatment with propranolol alone had no toxic effect on neurosphere production. A
slight but significant increase in the number of neurosphereswas also observed in the presence
of yohimbine alone. B, The selective 3 blocker SR59230A completely inhibited the
norepinephrine-mediated increase in neurosphere numbers. In contrast, the 1 receptor an-
tagonist CGP20712 had no effect, whereas the2 receptor antagonist ICI118,551 significantly
increasedneurospherenumbers both in thepresence andabsenceof norepinephrine.C, Expres-
sion of -adrenergic receptors in the sorted population of Hes5-GFP-positive and -negative
cells by reverse transcriptase-PCR showed the presence of the 3-adrenergic receptor exclu-
sively in the Hes5-positive population, whereas 1- and 2-adrenergic receptor transcripts
were expressed predominantly in the Hes5-negative population. Note that a small amount of
2 receptor mRNA was also detected in the Hes5-positive population. D, A similar increase in
neurosphere numbers was observed in the presence of a selective3-adrenergic receptor ag-
onist BRL37344 at 1 and 10M, comparedwith treatmentwith norepinephrine (mean SEM;
*p 0.05; **p 0.01; ***p 0.001).
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neural precursor activity in mice express-
ing GFP under the control of nestin. Mice
were treated once daily for 7 d with either
saline (vehicle control) or isoproterenol,
and dividing cells were again labeled with
BrdU. Systemic stimulation of -adrenergic
receptors resulted in a significant increase
in the total number of proliferating cells
in the SGZ (saline: 485.48  43.3 cells vs
isoproterenol: 769.15 55.4 cells; n 5;
p  0.0038; unpaired t test). More inter-
estingly, it also led to a significant increase
in the percentage of nestin-GFP/GFAP
double-positive cells, considered to be
quiescent neural precursors (for review,
see Kempermann et al., 2004) in the hip-
pocampus (Fig. 7F; saline: 31.00  2.9%
vs isoproterenol: 48.84 3.9%; p 0.011;
unpaired t test), confirming the activation
of a latent neural precursor population
in vivo.
Norepinephrine but not serotonin increases hippocampal
precursor activity in a novel “slice-sphere” assay ex vivo
The above finding that norepinephrine but not serotonin directly
activates hippocampal precursors prompted us to examine
whether agents such as antidepressants, which act primarily by
modulating levels of these neurotransmitters, exert their neuro-
genic effects by directly regulating hippocampal precursor activ-
ity. Given that the primary target of actions for these drugs
requires the presence of monoaminergic terminals, which can be
maintained only in an intact neurogenic niche, we reasoned that
the neurosphere assay, where such a niche would be lost, was less
suitable for this purpose. We therefore developed a two-step
slice-sphere assay (outlined in Fig. 8A–D), essentially combining
the advantages of organotypic slices, which retain the neurogenic
milieu, and the neurosphere assay, which serves as a measure of
quantifying precursor numbers. Hippocampal organotypic slices
prepared from 7-d-old neonatal rats retained a healthy appear-
ance after 6 d ex vivo in a serum-free culturemedium. Although a
significant reduction of 34% in cell number (n  4 experi-
ments, p  0.003; unpaired t test) was observed from the slices
cultured for 6 d (1.43 	 105  1.57 	 104 cells/ml) compared
with acute slices (day 0: 2.17 	 105  1.12 	 104 cells/ml), the
frequency of neurosphere formation was remarkably similar at
day 0 (28.46 0.6 neurospheres per 500 cells) and day 6 (25.01
2.1 neurospheres per 500 cells; p 0.216; unpaired t test), indi-
cating not only that the precursors were maintained in the slices
but also that they retained their normal proliferative capacity.
To determine the influence of an intact neurogenic niche and
validate the usefulness of the slice-sphere assay in mediating the
effects of serotonin or norepinephrine on precursor activity, hip-
pocampal slices were treated with various concentrations of these
neurotransmitters. The neurosphere frequency remained un-
changed in the slices treatedwith serotonin (10M: 90.07 5.4%
and 100 M: 102.81  31.7%) compared with the control (Fig.
8E). However, a twofold increase in precursor numbers was ob-
tained in the slice-sphere assay from slices treated with either 1
M ( p 0.026; unpaired t test) or 10 M norepinephrine ( p
0.023), consistent with our finding of an enhanced neurosphere
frequency in the conventional neurosphere assay. Notably, addi-
tion of 100 M norepinephrine to the slices led to a 3.5-fold
increase ( p 0.001) in the precursor activity compared with the
control. This suggests that serotonin is not able to modulate pre-
cursor activity even when the neurogenic niche is maintained.
Moreover, it highlights the importance of an intact neurogenic
niche in revealing a significantly larger increase in norepine-
phrine-dependent precursor activation than observed in the
standard neurosphere assay.
Antidepressants that block reuptake of norepinephrine but
not serotonin stimulate hippocampal precursor activity in
the slice-sphere assay
Finally, the above findings led us to examine the effect of two
major classes of antidepressants on hippocampal precursor activ-
ity. Fluoxetine, a prototypical SSRI, had no effect on precursor
numbers when added to the slices at a concentration of 1 M but
significantly reduced the neurosphere frequency at 10 M (Fig.
9A; p  0.04; unpaired t test). Although fluoxetine is a potent
uptake inhibitor of serotonin, it is also known to affect the activity
of muscarinic, histaminergic and -adrenergic receptors (Hyttel,
1994). Hence, the effect of another potent and more specific
SSRI, citalopram,was also examined.No significant change in the
hippocampal precursor frequency was observed at either 10 M
(113.8 9.9%) or 100M (103.8 3.8%) citalopram compared
with the control (Fig. 9A).
In contrast, reboxetine, a widely used NRI, produced a dose-
dependent increase in neurosphere numbers. While the fre-
quency of neurosphere formation remained unchanged at 1 M
(104.5 9.6%), a significant 40% increase was observed at 10M
( p 0.0026; unpaired t test), and more than a 2.5-fold increase
(265.0  11.7%; p  0.001) was observed at 100 M (Fig. 9B).
This stimulatory effect on hippocampal precursors was not ex-
clusive to reboxetine, being observed in the presence of other
members of the NRI family, namely atomoxetine and maproti-
line (Fig. 9B). Atomoxetine, at a concentration of 1M, increased
the precursor frequency to 147.0 15.0% (n 2 experiments),
comparable to the result obtained with 10 M reboxetine treat-
ment. Treatment of slices with 1 M maprotiline produced an
even greater increase (258.5 25.5%) in the frequency of neuro-
sphere formation compared with the control (n  2 experi-
ments). Together, these results suggest that antidepressants that
specifically block the reuptake of norepinephrine may exert their
neurogenic effects in the hippocampus primarily through activa-
Figure 7. Stimulation of 3-adrenergic receptors increases proliferation of hippocampal precursors in vivo. A–C, Bilateral
intrahippocampal microinfusion was verified on Nissl-stained sections. A, A representative coronal section showing the injection
track terminating in the hilus region of the hippocampus (Paxinos and Franklin, 2001). The hilus from one hemisphere received a
0.5l injection of 10M BRL37344 with the contralateral hemisphere receiving a control injection of 0.9% saline. B, C, Nissl-
stained sections showing the most ventral point of the microinfusion track (arrows) following infusion of 0.9% saline (B) or
BRL37344 (C). Scale bars, 200m. D, E, A representative micrograph showing BrdU-labeled cells along the SGZ in saline-treated
(D) versus BRL37344-treated (E) hippocampus. The granule cell layer is delineated by the dashed lines. Scale bars, 200m. F, A
confocal section showing colabeling of a nestin-GFP-positive cell (green)with GFAP (red) in the SGZ of isoproterenol-treatedmice.
Scale bar, 10m.
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tion of a precursor population. In contrast, serotonin and the
antidepressants that modulate its levels appear to have no direct
role in regulating hippocampal precursor activity.
Finally, to determine whether the norepinephrine- and
reboxetine-mediated increase in hippocampal precursor activity
involved -adrenergic receptors, slices were treated with 10 M
propranolol in the presence of either 10Mnorepinephrine or 10
M reboxetine (Fig. 9C). The ability of propranolol to completely
inhibit the norepinephrine-mediated ( p 0.036; unpaired t test)
as well as the reboxetine-mediated ( p  0.013) increase in
precursor activity indicated the involvement of -adrenergic
receptors.
Discussion
In the present study we have demonstrated that norepinephrine,
but not serotonin, activates a stem and precursor cell pool in the
adult hippocampus, and have provided evidence for a direct ac-
tion of norepinephrine on these precursors. Importantly, we have
uncovered a novel role for 3-adrenergic receptors in mediating
the norepinephrine-dependent activation of the hippocampal
precursors both in vitro and in vivo. Consistent with these results,
our findings from the slice-sphere assay demonstrate that antide-
pressants that selectively block the reuptake of norepinephrine
but not serotonin enhance hippocampal neurogenesis, primarily
by targeting the activity of stem and precursor cells.
The norepinephrine-responsive precursor population ap-
pears remarkably similar to the previously identified latent pop-
ulation of stem and precursor cells activated by depolarizing
levels of KCl (Walker et al., 2008). The most striking common
feature between norepinephrine- and KCl-mediated activation is
the emergence of a small number of very large neurospheres
(measuring 200 m in diameter), displaying the classic prop-
erties of stem cells, including self-renewal over multiple passages
and generation of multipotential lineages. However, the additive
effect in neurosphere numbers observed in the presence of both
norepinephrine and KCl is indicative of activation of different
pools of latent precursors. In fact, 5-fold increase in the number
of large neurospheres generated in the presence of both norepi-
nephrine and KCl, and the inability of a selective 3-adrenergic
receptor antagonist to block the KCl-dependent activation of the
precursors (data not shown), suggest the existence of a much
larger pool of latent precursors within the adult hippocampus
than previously considered. Also noteworthy is the ability of nor-
epinephrine to support neuronal production, with the majority
of primary neurospheres grown in the presence of norepineph-
rine containing III tubulin-positive neurons, and the larger
neurospheres containing in excess of 50 neurons. This highlights
the neurogenic potential of norepinephrine, which may underlie
the enhanced neurogenesis observed in vivo in response to NRIs
(Malberg et al., 2000). Thus, it appears that neural activity could
Figure 8. Direct application of norepinephrine but not serotonin enhances hippocampal
precursor activity in the slice-sphere assay. A, The hippocampus from a postnatal day 7 Wistar
rat was dissected and cut transversely into 300m slices. The slices were placed on a 0.4m
membrane filter thatwas bathed in 1ml of complete serum-free NeuroCultmedium in a 6-well
4
plate. Four filters, each containing 6–7 slices, were generated from a single animal. B, The
organotypic sliceswere cultured at a liquid-air interphase for a period of 6 d. Antidepressants or
neurotransmitterswere added to themediumon day 1 and half themediumwas replacedwith
fresh medium every alternate day. C, On the sixth day, the hippocampal slices were enzymati-
cally dissociated and cellswere plated in a 96-well plate and cultured in the presence of EGF and
bFGF to obtain neurospheres. D, The number of neurospheres generated was quantified after
10–12 d in culture, this being representative of the number of proliferating hippocampal pre-
cursors present in the slices. E, Serotonin (5-HT) treatment had no effect on the frequency of
neurosphere formation either at 10 or 100M. However, direct application of NE to the slices
resulted in an2-fold increase in the neurosphere frequency at 1 and 10M, and a 3.5-fold
increase at 100M (mean SEM; **p 0.01; ***p 0.001).
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regulate hippocampal neurogenesis in multiple ways. First,
neural excitation could transiently stimulate neurogenic activity
through the release of paracrine factors from the neurogenic niche
that could lead to a non-cell-autonomous activation of the latent
pool of neural precursors (Walker et al., 2008). Alternatively, neural
activity could lead to long-term changes in gene expression of the
factors associated with the neurogenic niche, such as brain-derived
neurotrophic factor and FGF-1b, by epigenetic mechanisms (Ma et
al., 2009). In contrast to these mechanisms, we propose a novel
mechanism whereby norepinephrine-mediated neural activity
could directly and locally enhance neural precursor activity via
3-adrenergic receptors, a possibility supported by the finding
that norepinephrine-containing afferents are found in close
proximity to proliferating precursors in the SGZ (Rizk et al.,
2006). Whether new neurons generated in the hippocampus in
response to firing of noradrenergic neurons in the locus ceruleus
or neural activity arising from other brain regions have similar or
different electrophysiological properties, and the behavioral con-
sequences of this, remains to be determined.
To date, the identity of the latent precursor population in the
adult hippocampus has remained elusive. In the present study,
we provide evidence that the Hes5-expressing population in the
adult hippocampal SGZ contains a subset of such latent precur-
sors.More importantly, we find that theHes5-expressing precur-
sor population comprises all the neurosphere-forming cells from
the adult hippocampus, including the stem cell population that
responds to norepinephrine. Expression of Hes5 in such a latent
precursor population is not surprising, given the essential role
that Notch signaling and Hes genes play in the maintenance of
neural stem and precursor cells in both the developing and the
adult nervous system (Kageyama et al., 2005). Moreover, similar
neurosphere frequency in bulk as well as clonal density (1 cell/
well) cultures of purifiedHes5-positive precursors confirmed the
direct effect of norepinephrine on adult hippocampal precursors
and ruled out the involvement of paracrine factors secreted from
other cells. This direct effect may underlie the twofold increase in
precursor activity observed in our slice-sphere assay in the pres-
ence of either norepinephrine or antidepressants that block the
reuptake of norepinephrine. Thus, we propose that Hes5 pro-
vides a valuable and robust marker for a subpopulation of stem
and precursor cells in the adult hippocampus and could be used
to examine the effects of other factors, including those released by
neural excitation (Walker et al., 2008).
A striking and unexpected finding of the current studywas the
expression of 3-adrenergic receptors exclusively on the Hes5-
positive precursor population. Until now, predominant expres-
sion of 3 receptors has only been reported in brown and white
adipose tissue (Strosberg, 1997), with a few reports examining
their expression in various brain tissues, including the hippocam-
pus (Summers et al., 1995; Claustre et al., 2008). Our evidence
that the nonselective -adrenergic receptor blocker proprano-
lol, as well as the selective 3-adrenergic receptor antagonist
SR59230A, completely inhibit the norepinephrine-dependent
stimulation of stem and precursor cells underpins a critical and
novel role for 3-adrenergic receptors in regulating adult hip-
pocampal precursor activity. This was further strengthened by
our finding that pharmacological stimulation of 3-adrenergic
receptors both in vitro and in vivo by the selective 3-adrenergic
receptor agonist BRL37344 led to enhanced proliferation of hip-
pocampal precursors. On the other hand, expression of 1 and
2 receptors in the Hes5-negative population was consistent
with the inability of their selective antagonists to block the
norepinephrine-mediated activation of precursors. In fact, a
Figure 9. NRIs but not SSRIs increase the activity of hippocampal precursors in the
slice-sphere assay. A, Slices treated with the SSRIs fluoxetine (1M) or citalopram (10 and
100M) showed no significant change in the frequency of neurosphere generation com-
pared with the untreated slices (control). Treatment with 10 M fluoxetine decreased
neurosphere frequency. B, Reboxetine, a prototypical NRI, significantly enhanced the
frequency of neurosphere formation at 10 and 100M. Treatment of slices with atomox-
etine and maprotiline also resulted in a significant increase in neurosphere frequency.
C, Blockade of -adrenergic receptors by propranolol (10 M) abolished both the
norepinephrine- and the reboxetine-mediated increase in neurosphere frequency
(mean SEM; *p 0.05; **p 0.01; ***p 0.001).
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marginal but significant potentiation effect was observed in the
presence of the 2 antagonist ICI118,551, suggesting an inhibi-
tory role for2-adrenergic receptors in regulating precursor pro-
liferation. Such an inhibitory role has recently been proposed for
another member of the adrenergic receptor family, namely 2-
adrenergic receptors (Yanpallewar et al., 2010), suggesting that
antagonism of 2-adrenergic receptors could also activate neural
precursors and result in an increase in neurosphere numbers as
observed in this study. Alternatively, 2-adrenergic receptor an-
tagonismmay enhance survival of neural precursors, a possibility
raised in a previous report (Rizk et al., 2006) that demonstrated
an 2-adrenergic receptor antagonist-mediated increase in the
survival of newborn neurons. Interestingly, 3-adrenergic recep-
tor blockade had no effect on the baseline proliferation of precur-
sors in the absence of norepinephrine. This raises the possibility
of a specific requirement of these receptors in mediating
norepinephrine-dependent regulation of hippocampal precur-
sors, including that mediated by NRIs.
How3-adrenergic receptorsmediate activation and prolifer-
ation of neural precursors is currently unknown. However, given
that 3-adrenergic receptors are seven transmembrane receptors
coupled to heterotrimeric G-proteins that signal via multiple in-
tracellular pathways, including activation of adenylate cyclase
and cAMP-dependent phosphorylation (for review, see Ursino et
al., 2009), and that increases in the intracellular levels of cAMP
regulate the proliferation of hippocampal precursors in vivo
(Nakagawa et al., 2002), it is possible that3-adrenergic receptor-
driven activation of neural precursors may also use this cAMP-
mediated signaling mechanism.
Also relevant to our findings are several reports describing
an antidepressant-like profile for the specific and potent 3-
adrenergic receptor agonist, SR58611A (amibegron) (Simiand et
al., 1992; Consoli et al., 2007; Stemmelin et al., 2008). Interest-
ingly, a study by Claustre et al. (2008) demonstrated that an
intraperitoneal injection of SR58611A produced an up to fivefold
increase in the level of hippocampal norepinephrine, consistent
with enhancement of the firing rate of noradrenergic neurons
present within the locus ceruleus. Given the dense innervation of
noradrenergic fibers in the dentate gyrus from the locus ceruleus,
together with our results demonstrating that norepinephrine can
directly activate multipotent precursors, it is tempting to specu-
late that the antidepressant-like effect of SR58611A observed in
animal models may occur via 3-adrenergic receptor-mediated
enhancement of hippocampal neurogenesis.
Finally, our data from both the standard neurosphere and
slice-sphere assays, together with the lack of any evidence for the
expression of serotonin receptors on neural precursors suggest
that serotonin and antidepressants that modulate levels of sero-
tonin neither directly nor via release of paracrine factors from the
neurogenic niche regulate hippocampal precursor activity. It is
possible that the previously reported neurogenic effects of SSRIs
on precursor activity (Gould, 1999; Malberg et al., 2000) require
more than just the local hippocampal niche. Given reports that
the effects of SSRIs, including fluoxetine, are lost in norepine-
phrine-deficient mice, it has been suggested that some of these
effectsmay involve a role for norepinephrine (Cryan et al., 2004).
Alternatively, it has been proposed that the neurogenic effects of
fluoxetine require circadian rhythm-associated changes in the
level of corticosterone (Huang and Herbert, 2006). It must also
be noted that the slice-sphere assay used postnatal day 7 animals,
primarily due to the ease of maintaining healthy hippocampal
slices ex vivo. Although many of the factors that regulate adult
neurogenesis are present in the developing hippocampus, there
may be a lack of specific inputs or other factors in the early post-
natal brain which preclude the proliferating effects of SSRIs.
Nonetheless, recent studies have shown that neither selective de-
pletion or enhancement of serotonin (Jha et al., 2006) nor
chronic treatment with fluoxetine have any effect on hippocam-
pal precursor proliferation in vivo (Couillard-Despres et al., 2009;
David et al., 2009). Instead, improved survival and morphologi-
cal changes in doublecortin-positive cells suggest a role for fluox-
etine during maturation of newly born neurons (Wang et al.,
2008; David et al., 2009).
In summary, our findings suggest that stimulation of 3-
adrenergic receptors can directly activate a distinct population of
precursors, including stem cells, to generate a large number of
neurons in the adult hippocampus. This opens up the possibility
of developing novel pharmaceutical agents to enhance neurogen-
esis as ameans of treating a variety of psychiatric diseases, includ-
ing depression.
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